74 related articles for article (PubMed ID: 4581185)
21. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
Feugier P; Van Hoof A; Sebban C; Solal-Celigny P; Bouabdallah R; Fermé C; Christian B; Lepage E; Tilly H; Morschhauser F; Gaulard P; Salles G; Bosly A; Gisselbrecht C; Reyes F; Coiffier B
J Clin Oncol; 2005 Jun; 23(18):4117-26. PubMed ID: 15867204
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
26. Letter: Chemotherapy of advanced histocytic lymphomas.
Sweet D; Golomb H; Desser R; Ultmann JE; Yachnin S; Stein R
Lancet; 1975 May; 1(7916):1136. PubMed ID: 49488
[No Abstract] [Full Text] [Related]
27. [Chemotherapy of lymphogranulomatosis].
Schmidt CG
Internist (Berl); 1974 Feb; 15(2):93-102. PubMed ID: 4600311
[No Abstract] [Full Text] [Related]
28. Advanced diffuse histiocytic lymphoma, a potentially curable disease.
DeVita VT; Canellos GP; Chabner B; Schein P; Hubbard SP; Young RC
Lancet; 1975 Feb; 1(7901):248-50. PubMed ID: 46388
[TBL] [Abstract][Full Text] [Related]
29. Diffuse large B-cell lymphoma.
Ng AK
Semin Radiat Oncol; 2007 Jul; 17(3):169-75. PubMed ID: 17591563
[TBL] [Abstract][Full Text] [Related]
30. [Clinical experience with procarbazine in malignant lymphomas--single and combination (VENP) therapy].
Shimoyama M; Kitahara T; Sakano T; Konda C; Sakai Y
Rinsho Ketsueki; 1973 Jun; 14(6):668-75. PubMed ID: 4738281
[No Abstract] [Full Text] [Related]
31. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
Sonet A; Bosly A
Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
[TBL] [Abstract][Full Text] [Related]
32. Primary mediastinal large B-cell lymphoma.
Ergul SM; Lal A; Afri L; Frei-Lahr D
South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the Lukes and Collins classification in patient treated with COMLA.
Sweet DL; Collins RD; Stein RS; Ultmann JE
Cancer Treat Rep; 1982 May; 66(5):1107-11. PubMed ID: 7044531
[TBL] [Abstract][Full Text] [Related]
34. Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant.
Armitage JO; Dick FR; Corder MP
Cancer Treat Rep; 1981; 65(5-6):413-8. PubMed ID: 7016324
[TBL] [Abstract][Full Text] [Related]
35. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
[TBL] [Abstract][Full Text] [Related]
36. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
[TBL] [Abstract][Full Text] [Related]
37. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy.
Dai CW; Zhang GS; Pei MF; Shen JK
Ann Hematol; 2009 Jul; 88(7):701-2. PubMed ID: 19015853
[No Abstract] [Full Text] [Related]
38. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
[No Abstract] [Full Text] [Related]
39. Recent advances in chemotherapy of lymphoma.
Lenhard RE; Owens AH
Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
[No Abstract] [Full Text] [Related]
40. Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study.
García-Suárez J; Bañas H; Arribas I; De Miguel D; Pascual T; Burgaleta C
Br J Haematol; 2007 Jan; 136(2):276-85. PubMed ID: 17233819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
